Skip to main content

Farallon Capital Management Llc

Source: SEC Form 13F · as of Mar 2026

Farallon Capital Management Llc holds 51 biotech & pharma companies tracked by BioSniper, totaling $4.93B in value as of Mar 2026 (SEC Form 13F).

Companies held

51

Total value held

$4.93B

BioSniper AIPage evidence connected

Prepared research question

What matters most for REVOLUTION MEDICINES, INC. (RVMD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
RVMDREVOLUTION MEDICINES, INC.13,604,796$1.32B
BBIOBridgeBio Pharma, Inc.9,365,463$695.5M
PTGXProtagonist Therapeutics, Inc6,348,906$669.2M
EXELEXELIXIS, INC.13,111,010$562.3M
LQDALiquidia Corp8,656,038$326.7M
ROIVRoivant Sciences Ltd.9,675,000$268.0M
BEAMBeam Therapeutics Inc.10,134,696$241.5M
AGIOAGIOS PHARMACEUTICALS, INC.5,684,000$192.3M
CNTACentessa Pharmaceuticals plc4,809,000$191.0M
TNGXTango Therapeutics, Inc.9,097,411$190.3M
PCVXVaxcyte, Inc.1,261,000$73.3M
DNTHDianthus Therapeutics, Inc. /DE/836,000$70.2M
IMVTImmunovant, Inc.1,546,000$38.4M
ASMBASSEMBLY BIOSCIENCES, INC.1,227,590$34.1M
AVTXAvalo Therapeutics, Inc.916,000$13.7M
MAZEMaze Therapeutics, Inc.373,000$11.1M
TEVATeva Pharmaceutical Industries Limited354,000$10.7M
RNAAtrium Therapeutics Inc.349,360$4.7M
IRDOpus Genetics, Inc.1,000,000$4.5M
CAPRCAPRICOR THERAPEUTICS, INC.41,000$1.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.15,800$991K
ALVOAlvotech199,675$685K
AXSMAxsome Therapeutics, Inc.4,000$676K
COGTCogent Biosciences, Inc.17,000$654K
ARQTArcutis Biotherapeutics, Inc.26,000$613K
TERNTerns Pharmaceuticals, Inc.7,000$369K
IONSIONIS PHARMACEUTICALS INC4,800$360K
TVTXTravere Therapeutics, Inc.12,000$357K
SRRKScholar Rock Holding Corp7,000$344K
ONCBeOne Medicines Ltd.1,100$327K
NUVLNuvalent, Inc.3,000$307K
STOKStoke Therapeutics, Inc.9,000$293K
NKTRNEKTAR THERAPEUTICS4,000$288K
ALMSALUMIS INC.11,000$242K
APLSApellis Pharmaceuticals, Inc.6,000$241K
FOLDAMICUS THERAPEUTICS, INC.16,000$231K
QUREuniQure N.V.14,000$229K
GRFSGrifols S.A.28,000$225K
ABVXAbivax SA2,000$223K
SUPNSUPERNUS PHARMACEUTICALS, INC.4,000$207K
PGENPRECIGEN, INC.50,000$194K
SLSSELLAS Life Sciences Group, Inc.40,000$169K
ADPTAdaptive Biotechnologies Corp11,000$153K
OCULOCULAR THERAPEUTIX, INC18,000$152K
ARDXARDELYX, INC.23,000$138K
NUVBNuvation Bio Inc.29,000$124K
IOVAIOVANCE BIOTHERAPEUTICS, INC.26,000$91K
ALTAltimmune, Inc.27,600$85K
CCCCC4 Therapeutics, Inc.28,000$74K
TVRDTvardi Therapeutics, Inc.21,438$68K
GERNGERON CORP43,000$64K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.